BPaL/M is a six-month all-oral regimen recommended by the World Health Organization (WHO) to treat most forms of ...

In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is ...

Global access to tuberculosis (TB) medicine pretomanid received a shot in the arm, as its price saw a 25% drop, thanks to a ...

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, ...

TB Alliance's third licensed manufacturer makes pretomanid available through the Global Drug Facility, further improving affordability and access ...

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not ...

Acknowledging India’s contribution to TB vaccine research, Dr. Swaminathan noted that the overall TB vaccine pipeline remains ...

Researchers hope that this new approach will inform guidance from global health organizations and key decision-makers on the most effective way to screen for TB. TB is one of the deadliest ...

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...

The GHIT Fund awards two-year grant to Fujirebio subsidiary Fluxus to develop an ultrasensitive point-of-care (POC) urine test for tuberculosis (TB).